product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-CREB (Ser133) (1B6) Mouse mAb
catalog :
9196L
quantity :
300 ul
price :
658 USD
clonality :
monoclonal
host :
mouse
antigen modification :
phosphorylated
clone name :
1B6
reactivity :
human, mouse, rat
application :
western blot
more info or order :
citations: 3
Published Application/Species/Dilution | Reference |
---|---|
| |
| Zhang Y, Lin R, Tao J, Wu Y, Chen B, Yu K, et al. Electroacupuncture improves cognitive ability following cerebral ischemia reperfusion injury via CaM-CaMKIV-CREB signaling in the rat hippocampus. Exp Ther Med. 2016;12:777-782 pubmed
|
product information
SKU :
9196L
Product-Name :
Phospho-CREB (Ser133) (1B6) Mouse mAb
Size :
300 ul
Price-(USD) :
658 USD
Species-x-Reactivity :
H, M, R
Applications :
Western blot
Product-Category :
Neuroscience
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
43
Host :
Mouse
Target :
CREB (Ser133) phosphate
Primary-Protein :
CREB
Alt-Names :
CREB,CREB-1,CREB1,Cyclic AMP-responsive element-binding protein 1,MGC9284,active transcription factor CREB,cAMP responsive element binding protein 1,cAMP-response element-binding protein-1,cAMP-responsive element-binding protein 1,transactivator protein
more info or order :
company information
Cell Signaling Technology
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.
review
product type
related products
browse more products
questions and comments